BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 10, 2026
Home » Blogs » BioWorld Perspectives » Michele Bachmann Endangered Women’s Lives

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld / Drug resistance / Cancer

Michele Bachmann Endangered Women’s Lives

Sep. 14, 2011
By Lynn Yoffee

Teary-eyed mother to Michele Bachmann: Michele, my daughter took the HPV vaccine and spontaneously became mentally retarded.

Michele Bachmann to the world: We must stop the use of these dangerous government-mandated vaccines which infringe on our liberties as Americans and cause mental retardation.

Those aren’t direct quotes . . . but it was the gist of the exchange. I cringed when I read the news reports. It was more than a misstatement; it’s a potential death sentence for the untold number of girls and women who might be lead astray by this heinous misinformation put forth by GOP presidential hopeful, Rep. Michele Bachmann (R-Minn). In her ignorant efforts to get political attention – and push her ultra-conservative, head-in-the-sand agenda – she stepped way over the line when commenting on an executive order issued by presidential candidate, Gov. Rick Perry in 2007, which requires that schoolgirls in Texas receive a vaccine that would protect them against sexually transmitted human papillomavirus, a known cause of cervical cancer.

Let’s put aside issues of personal liberty as they relate to vaccines in general (an endless debate), issues related to teen sex and political donations from Merck, the maker of anti-HPV vaccine Gardasil, to candidate Perry. Bachmann used her current position in the limelight to deliver a statement with potential catastrophic results. Not only did she create unnecessary doubt and fear among the millions of parents who want to protect their children from the ravages of cancer, she proved herself to be a complete idiot.

Is this who would potentially run the world’s most powerful nation? She who does not respect the facts of science and repeated clinical trials, or the fact that the FDA has deemed this vaccine and others to provide more benefit than harm? She would, instead, opt to promote the misinformation put forth by one teary-eyed, confused mother out of a crowd of fans. It’s just downright chilling.

Here’s a real, documented fact from the Centers for Disease Control and Prevention:

In 2007 (the most recent year numbers are available), 12,280 women in the U.S. were diagnosed with cervical cancer and 4,021 women died from this disease. Cancer vaccines help to slow those death rates, as proven in the clinical trials required to gain drug approval.

Here’s my direct request to Bachmann: Read and research first. Then speak about what you’ve learned. Please. It’s a matter of life or death.

Years later, another teary-eyed mother: Michele, I took your advice and refused to allow my daughter to get the Gardasil vaccine. She acquired HPV as a young teen and now has cervical cancer and I don’t know if she’ll survive.

Michele Bachmann: We’ll pray for your daughter.

Mother: Gee, thanks.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Art concept for inflammation in the intestines

    Kymera’s IRF5 degrader shows potential in IBD treatment

    BioWorld Science
    At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing